摘要
背景:慢性疼痛状态在临床上是相关的,但仍未得到解决,影响到生活质量,并代表着一个重要的社会和经济负担;这些疾病是很糟糕的。与现有药物相结合,急需创新的止痛药。 在这个框架内,新的类似物的内吗啡-1和德吗啡成为开发创新的,更有效的止痛药治疗神经病理性疼痛的有希望的起点。 方法:利用重点复习问题,对同行评审文献的书目数据库进行广泛、结构化的检索;所有检索到的论文均在p上发表。该领域的专家对国际期刊进行了仔细分析,以收集本审查概念框架所需的所有信息和数据。 结果:本文共收录文献100篇,其中41篇介绍了最新的神经病理、疼痛、病因病机及目前可用的治疗方案。三十五位爸爸RS描述了在神经病理性疼痛框架中使用内吗啡素-1(23)或德吗啡(12)的所有优点和缺点,并概述了在发展内吗啡-1和dee方面的最相关进展。魔芋素类似物作为潜在的,创新的止痛药。 24篇论文提供了关于利用阿片受体有偏倚的激动剂作为一种创新策略来开发更有效和更安全的镇痛剂的最新见解。 结论:本综述报告,创新阿片肽将有助于更好地理解神经病理性疼痛治疗的多方面情况,提供非常有趣的操作。用于鉴别新的和更有效的阿片类镇痛药作为药物的统一性。
关键词: μ阿片受体,δ阿片受体,卡帕阿片受体,内吗啡,皮素,偏倚激动剂,创新镇痛药。
Current Medicinal Chemistry
Title:Innovative Opioid Peptides and Biased Agonism: Novel Avenues for More Effective and Safer Analgesics to Treat Chronic Pain
Volume: 25 Issue: 32
关键词: μ阿片受体,δ阿片受体,卡帕阿片受体,内吗啡,皮素,偏倚激动剂,创新镇痛药。
摘要: Background: Chronic pain states are clinically relevant and yet unsolved conditions impacting on quality of life and representing an important social and economic burden; these diseases are poorly treated with the currently available drugs, being urgent the need of innovative analgesics.
In this frame, novel analogues of endomorphin-1 and dermorphin emerge as promising starting points to develop innovative, more effective analgesics to treat neuropathic pain.
Methods: An extensive and structured search of bibliographic databases for peer-reviewed research literature was undertaken using focused review questions; all the retrieved papers were published on prestigious international journals by the experts of the field and were carefully analyzed to collect all the information and data necessary to the conceptual framework of this review.
Results: One hundred papers were included in this review; forty-one defined the up-to-date findings on neuropathic pain etiopathogenesis and its currently available treatment options. Thirty-five papers described all the advantages and drawbacks of using endomorphin-1 (23) or dermorphin (12) in the frame of neuropathic pain and outlined the most relevant advances in developing endomorphin-1 and dermorphin analogs useful as potential, innovative analgesics.
Twenty-four papers provided the latest insights into exploiting biased agonism at opioid receptor as an innovative strategy to develop more effective and safer analgesics.
Conclusion: This review reports that innovative opioid peptides will be of great help in better understanding the multifaceted scenario of neuropathic pain treatment, providing very interesting opportunities for the identification of novel and more effective opioid analgesics to be employed as medications.
Export Options
About this article
Cite this article as:
Innovative Opioid Peptides and Biased Agonism: Novel Avenues for More Effective and Safer Analgesics to Treat Chronic Pain, Current Medicinal Chemistry 2018; 25 (32) . https://dx.doi.org/10.2174/0929867324666170216095233
DOI https://dx.doi.org/10.2174/0929867324666170216095233 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?
Current Topics in Medicinal Chemistry MicroRNA-34a Promotes Cardiomyocyte Apoptosis Post Myocardial Infarction Through Down-regulating Aldehyde Dehydrogenase 2
Current Pharmaceutical Design Bioengineering RNA Silencing Across the Life Kingdoms
Recent Patents on Biotechnology Nitric Oxide-Releasing Biomaterials for Biomedical Applications
Current Medicinal Chemistry Gene and Stem Cell Therapy in the Treatment of Erectile Dysfunction and Pulmonary Hypertension; Potential Treatments for the Common Problem of Endothelial Dysfunction
Current Gene Therapy The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?
Current Drug Therapy Neurological Disorders in Pregnancy
Current Women`s Health Reviews The Chemistry and Pharmacology of Genistein
The Natural Products Journal The Role of Sympathetic Nervous System in the Progression of Chronic Kidney Disease in the Era of Catheter Based Sympathetic Renal Denervation
Current Clinical Pharmacology Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?
Current Pharmaceutical Design Association Between Polycystic Ovary Syndrome and Metabolic Syndrome
Current Medicinal Chemistry Precision-Cut Organ Slices as a Tool to Study Toxicity and Metabolism of Xenobiotics with Special Reference to Non-Hepatic Tissues
Current Drug Metabolism Serum Specific Vasopressin-Degrading Activity is Related to Blood Total Cholesterol Levels in Men but not in Women
Medicinal Chemistry Incremental Value of Two Dimensional Speckle Tracking Echocardiography in the Functional Assessment and Characterization of Subclinical Left Ventricular Dysfunction
Current Cardiology Reviews Present Insights on Cardiomyopathy in Diabetic Patients
Current Diabetes Reviews Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease
Current Alzheimer Research Respiratory Muscle Dysfunction in COPD: From Muscle to Cell
Current Drug Targets Actions of Selected Cardiovascular Hormones on Arterial Stiffness and Wave Reflections
Current Pharmaceutical Design Retracted: Tocotrienols and its Role in Cardiovascular Health- a Lead for Drug Design
Current Pharmaceutical Design Mathematical Methods to Analysis of Topology, Functional Variability and Evolution of Metabolic Systems Based on Different Decomposition Concepts
Current Drug Metabolism